102. ルビンシュタイン・テイビ症候群 Rubinstein-Taybi syndrome Clinical trials / Disease details
臨床試験数 : 3 / 薬物数 : 8 - (DrugBank : 1) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 17
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|